Literature DB >> 8680734

Behavioural interactions between 5-hydroxytryptophan, neuroleptic agents and 5-HT receptor antagonists in modifying rodent responding to aversive situations.

B Costall1, R J Naylor.   

Abstract

1. The ability of 5-hydroxytryptophan, 5-HT2 receptor antagonists and typical and atypical neuroleptic agents to modify behavioural responding to aversive situations was investigated in the mouse light/dark test and rat social interaction. 2. The administration of 5-hydroxytryptophan inhibited rat social interaction and the exploratory behaviour of mice in the light/dark test. 3. The 5-HT2 receptor antagonists, ketanserin, ritanserin, MDL11939, methysergide and RP62203, the neuroleptic agents, spiperone, haloperidol and benperidol, and the atypical neuroleptic agent, clozapine, when administered alone failed to modify mouse or rat behaviour. In contrast, when administered alone, sulpiride in rats and mice and thioridazine in rats disinhibited behaviour. 4. Methysergide, RP62203, ketanserin, ritanserin and MDL11939 antagonized the inhibitory effects of 5-hydroxytryptophan or reversed the inhibitory effects to one of disinhibition. 5. Low doses of spiperone (but not haloperidol or benperidol) also antagonized the inhibitory effects of 5-hydroxytryptophan in the rat but not the mouse. Higher doses of the three neuroleptic agents caused locomotor depression in both rats and mice which obscured any specific changes in behavioural responding to the aversive situations. 6. The disinhibitory profile of sulpiride in both mice and rats and thioridazine in rats was evident during their interaction with 5-hydroxytryptophan. Thioridazine in the mouse and clozapine in rats and mice also reversed the inhibitory effects of 5-hydroxytryptophan to one of disinhibition. 7. In summary, we present evidence that the atypical neuroleptic agents, thioridazine and clozapine, with their known affinity for the 5-HT2 receptors, can mimic the actions of reference 5-HT2 receptor antagonists to antagonize the inhibitory effects of 5-hydroxytryptophan in rodent models of anxiety. The results are intepreted in terms of drug action on different 5-HT2 and other 5-HT receptor subtypes. In addition, thioridazine and sulpiride have disinhibitory effects in their own right which remain to be explained.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8680734      PMCID: PMC1909209          DOI: 10.1111/j.1476-5381.1995.tb15954.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  33 in total

1.  Serotonergic involvement with neuroleptic catalepsy.

Authors:  B Costall; D H Fortune; R J Naylor; C D Mardsen; C Pycock
Journal:  Neuropharmacology       Date:  1975-11       Impact factor: 5.250

Review 2.  Major tranquillisers used as antidepressants. A review.

Authors:  M M Robertson; M R Trimble
Journal:  J Affect Disord       Date:  1982-09       Impact factor: 4.839

3.  The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs.

Authors:  S E File
Journal:  J Neurosci Methods       Date:  1980-06       Impact factor: 2.390

4.  Does ritanserin, a potent serotonin-S2 antagonist, restore energetic functions during the night?

Authors:  P A Janssen
Journal:  J R Soc Med       Date:  1987-07       Impact factor: 5.344

5.  Antagonism of the hyperactivity induced by dopamine applied intracerebrally to the nucleus accumbens septi by typical neuroleptics and by clozapine, sulpiride and thioridazine.

Authors:  B Costall; R J Naylor
Journal:  Eur J Pharmacol       Date:  1976-01       Impact factor: 4.432

6.  The risks and benefits of clozapine versus chlorpromazine.

Authors:  J Claghorn; G Honigfeld; F S Abuzzahab; R Wang; R Steinbook; V Tuason; G Klerman
Journal:  J Clin Psychopharmacol       Date:  1987-12       Impact factor: 3.153

7.  A randomized double blind group comparative study of sulpiride and amitriptyline in affective disorder.

Authors:  H M Standish-Barry; N Bouras; P K Bridges; J P Watson
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

8.  Antidepressant drugs normalize the increased social behaviour of pairs of male rats induced by short term isolation.

Authors:  R J Niesink; J M Van Ree
Journal:  Neuropharmacology       Date:  1982-12       Impact factor: 5.250

9.  Actions of sulpiride and tiapride in a simple model of anxiety in mice.

Authors:  B Costall; C A Hendrie; M E Kelly; R J Naylor
Journal:  Neuropharmacology       Date:  1987 Feb-Mar       Impact factor: 5.250

10.  Recent developments in 5HT-related pharmacology of animal models of anxiety.

Authors:  C R Gardner
Journal:  Pharmacol Biochem Behav       Date:  1986-05       Impact factor: 3.533

View more
  6 in total

1.  Antagonist functional selectivity: 5-HT2A serotonin receptor antagonists differentially regulate 5-HT2A receptor protein level in vivo.

Authors:  Prem N Yadav; Wesley K Kroeze; Martilias S Farrell; Bryan L Roth
Journal:  J Pharmacol Exp Ther       Date:  2011-07-07       Impact factor: 4.030

Review 2.  The neonatal ventral hippocampal lesion as a heuristic neurodevelopmental model of schizophrenia.

Authors:  Kuei Y Tseng; R Andrew Chambers; Barbara K Lipska
Journal:  Behav Brain Res       Date:  2008-12-03       Impact factor: 3.332

3.  Motivational assessment of mice using the touchscreen operant testing system: effects of dopaminergic drugs.

Authors:  Christopher J Heath; Timothy J Bussey; Lisa M Saksida
Journal:  Psychopharmacology (Berl)       Date:  2015-07-10       Impact factor: 4.530

4.  Behavioral Effects of Acute Systemic Low-Dose Clozapine in Wild-Type Rats: Implications for the Use of DREADDs in Behavioral Neuroscience.

Authors:  Ann-Kathrin Ilg; Thomas Enkel; Dusan Bartsch; Florian Bähner
Journal:  Front Behav Neurosci       Date:  2018-08-14       Impact factor: 3.558

5.  The alkaloid alstonine: a review of its pharmacological properties.

Authors:  E Elisabetsky; L Costa-Campos
Journal:  Evid Based Complement Alternat Med       Date:  2006-01-16       Impact factor: 2.629

6.  Pharmacological rescue of Ras signaling, GluA1-dependent synaptic plasticity, and learning deficits in a fragile X model.

Authors:  Chae-Seok Lim; Elizabeth T Hoang; Kenneth E Viar; Ruth L Stornetta; Michael M Scott; J Julius Zhu
Journal:  Genes Dev       Date:  2014-02-01       Impact factor: 11.361

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.